Table 1. ZIKV-derived H-2b-restricted epitopes and JEV variants.
| Peptidesa | Sequencesb | Homologyc |
|---|---|---|
| ZIKV-prM44-52 | ATMSYECPM | 56% |
| JEV-prM47-55 | DTITYECPK | |
| ZIKV-E4-12 | IGVSNRDFV | 56% |
| JEV-E4-12 | LGMGNRDFI | |
| ZIKV-E57-65 | RSYCYEASI | 78% |
| JEV-E57-65 | RSYCYHASV | |
| ZIKV-E420-428 | RMAVLGDTA | 78% |
| JEV-E416-424 | RLAALGDTA | |
| ZIKV-NS3276-284 | SSIAARGYI | 89% |
| JEV-NS3293-301 | ASIAARGYI | |
| ZIKV-NS3347-355 | PSVRNGNEI | 67% |
| JEV-NS3364-372 | ASVKMGNEI | |
| ZIKV-NS568-77 | SSLVNGVVRL | 90% |
| JEV-NS5320-329 | SSLVNGVVKL | |
| ZIKV-NS5222-229 | RAIWYMWL | 88% |
| JEV-NS5474-481 | RAIWFMWL |
a
Peptide position is determined according to the amino acid sequence of ZIKV strain and JEV strain.
b
The shared amino acid residue is underlined.
c
The percentage of shared amino acid between ZIKV epitope and JEV variant.